Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2006

01-05-2006 | Case Report

Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus

Authors: Jong-Ho Won, Seung-Hyo Han, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taeg Lee, Sung-Kyu Park, Dae-Sik Hong, Dong-Wha Lee, Hee-Sook Park

Published in: International Journal of Hematology | Issue 4/2006

Login to get access
Metadata
Title
Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus
Authors
Jong-Ho Won
Seung-Hyo Han
Sang-Byung Bae
Chan-Kyu Kim
Nam-Su Lee
Kyu-Taeg Lee
Sung-Kyu Park
Dae-Sik Hong
Dong-Wha Lee
Hee-Sook Park
Publication date
01-05-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.A30510

Other articles of this Issue 4/2006

International Journal of Hematology 4/2006 Go to the issue

Case Report

Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor

Case Report

Hypocalcemic Heart Failure in Thalassemic Patients

Letter to the Editor

A Case of Hand-Mirror Cell Variant of Multiple Myeloma

Progress in Hematology

New Therapeutic Approach for Myeloid Leukemia: Induction of Apoptosis via Modulation of Reactive Oxygen Species Production by Natural Compounds

Letter to the Editor

Successful Autologous Hematopoietic Stem Cell Transplantations for Severe Multiple Sclerosis with Fludarabine and Cyclophosphamide Conditioning

Letter to the Editor

Methotrexate-Associated Lymphoproliferative Disorder Mimicking Composite Lymphoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits